Diagnosis & treatment of tuberculosis in HIV co-infected patients.
Human immunodeficiency virus (HIV) associated tuberculosis (TB) remains a major global public health challenge, with an estimated 1.4 million patients worldwide. Co-infection with HIV leads to challenges in both the diagnosis and treatment of tuberculosis. Further, there has been an increase in rates of drug resistant tuberculosis, including multi-drug (MDR-TB) and extensively drug resistant TB (XDRTB), which are difficult to treat and contribute to increased mortality. Because of the poor performance of sputum smear microscopy in HIV-infected patients, newer diagnostic tests are urgently required that are not only sensitive and specific but easy to use in remote and resource-constrained settings. The treatment of co-infected patients requires antituberculosis and antiretroviral drugs to be administered concomitantly; challenges include pill burden and patient compliance, drug interactions, overlapping toxic effects, and immune reconstitution inflammatory syndrome. Also important questions about the duration and schedule of anti-TB drug regimens and timing of antiretroviral therapy remain unanswered. From a programmatic point of view, screening of all HIV-infected persons for TB and vice-versa requires good co-ordination and communication between the TB and AIDS control programmes. Linkage of co-infected patients to antiretroviral treatment centres is critical if early mortality is to be prevented. We present here an overview of existing diagnostic strategies, new tests in the pipeline and recommendations for treatment of patients with HIV-TB dual infection.
National Institute for Research in Tuberculosis (Indian Council of Medical Research), No.1 Sathiyamoorthy Road, Chetpet, Chennai, India.
C
C
Padmapriyadarsini
G
G
Narendran
Soumya
S
Swaminathan
D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects / Q000379:methods*; D060085:Coinfection / Q000188:drug therapy* / Q000517:prevention & control; D003948:Diagnostic Techniques, Respiratory System; D004334:Drug Administration Schedule; D004347:Drug Interactions; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000209:etiology*; D010349:Patient Compliance; D015980:Public Health Practice; D012698:Serologic Tests / Q000379:methods; D014376:Tuberculosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control